Additionally, this medication is not recommended for pregnant or breastfeeding women, as its safety in these populations has not been established
Pharmacy Services Administrative Organizations (PSAOs) 5.4
Efinopegdutide administered once weekly at 10 mg produced a greater hepatic fat decrease than semaglutide 1 mg in patients with NAFLD (LS mean -72.7% vs
This single step reduces injection discomfort more than almost any other technique adjustment
patients in these groups should discuss their suitability with a clinician before participating in any trial Dietary habits high-fat or heavily spiced meals may exacerbate symptoms Diarrhoea in this context is a pharmacological side effect , not an allergic reaction or sign of serious harm in most cases
West, S., Scragg, J., Aveyard, P., Oke, J